This is a Validated Antibody Database (VAD) review about mouse Sfrp1, based on 4 published articles (read how Labome selects the articles), using Sfrp1 antibody in all methods. It is aimed to help Labome visitors find the most suited Sfrp1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Sfrp1 synonym: 2210415K03Rik; AW011917; AW107218; AW742929; sFRP-1; secreted frizzled-related protein 1; secreted frizzled-related sequence protein 1

Abcam
rabbit polyclonal
  • western blot; mouse; loading ...; fig 2b
In order to show that decreased WNT/beta-catenin contributes to the pathophysiology of lamin A/C gene cardiomyopathy, Abcam Sfrp1 antibody (Abcam, ab4193) was used in western blot on mouse samples (fig 2b). Hum Mol Genet (2017) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 1
In order to develop a CRISPR/Cas9-mediated method for somatic gene disruption, Abcam Sfrp1 antibody (Abcam, ab4193) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1). Nat Commun (2015) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:200
Abcam Sfrp1 antibody (Abcam, ab4193) was used in immunohistochemistry on human samples at 1:200. Stem Cells (2013) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:800
In order to characterize osteoblastic and osteolytic proteins in prostate cancer bone metastases, Abcam Sfrp1 antibody (Abcam, Ab4193) was used in immunohistochemistry - paraffin section on human samples at 1:800. Prostate (2013) ncbi
Articles Reviewed
  1. Le Dour C, Macquart C, Sera F, Homma S, Bonne G, Morrow J, et al. Decreased WNT/?-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene. Hum Mol Genet. 2017;26:333-343 pubmed publisher
  2. Zuckermann M, Hovestadt V, Knobbe Thomsen C, Zapatka M, Northcott P, Schramm K, et al. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun. 2015;6:7391 pubmed publisher
  3. Manoranjan B, Wang X, Hallett R, Venugopal C, Mack S, McFarlane N, et al. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells. Stem Cells. 2013;31:1266-77 pubmed publisher
  4. Larson S, Zhang X, Dumpit R, Coleman I, Lakely B, Roudier M, et al. Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases. Prostate. 2013;73:932-40 pubmed publisher